CN110613754A - Traditional Chinese medicine composition for treating pancreatitis and application thereof - Google Patents
Traditional Chinese medicine composition for treating pancreatitis and application thereof Download PDFInfo
- Publication number
- CN110613754A CN110613754A CN201911098853.2A CN201911098853A CN110613754A CN 110613754 A CN110613754 A CN 110613754A CN 201911098853 A CN201911098853 A CN 201911098853A CN 110613754 A CN110613754 A CN 110613754A
- Authority
- CN
- China
- Prior art keywords
- traditional chinese
- chinese medicine
- medicine composition
- pancreatitis
- raw materials
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 88
- 239000000203 mixture Substances 0.000 title claims abstract description 58
- 206010033645 Pancreatitis Diseases 0.000 title claims abstract description 46
- 239000002994 raw material Substances 0.000 claims abstract description 21
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 14
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 14
- 240000000233 Melia azedarach Species 0.000 claims abstract description 14
- 241000096270 Swertia leducii Species 0.000 claims abstract description 14
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 14
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 13
- 235000011477 liquorice Nutrition 0.000 claims abstract description 13
- 235000010662 Bidens pilosa Nutrition 0.000 claims abstract description 12
- 244000104272 Bidens pilosa Species 0.000 claims abstract description 10
- 240000004980 Rheum officinale Species 0.000 claims abstract description 7
- 235000008081 Rheum officinale Nutrition 0.000 claims abstract description 7
- 206010033647 Pancreatitis acute Diseases 0.000 claims description 15
- 201000003229 acute pancreatitis Diseases 0.000 claims description 15
- 208000000668 Chronic Pancreatitis Diseases 0.000 claims description 14
- 206010033649 Pancreatitis chronic Diseases 0.000 claims description 14
- 229940079593 drug Drugs 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 22
- 208000002193 Pain Diseases 0.000 abstract description 8
- 230000036407 pain Effects 0.000 abstract description 8
- 239000000126 substance Substances 0.000 abstract description 5
- 231100000331 toxic Toxicity 0.000 abstract description 5
- 230000002588 toxic effect Effects 0.000 abstract description 5
- 230000008506 pathogenesis Effects 0.000 abstract description 3
- 238000002360 preparation method Methods 0.000 abstract description 2
- 238000001356 surgical procedure Methods 0.000 abstract description 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 2
- 238000012216 screening Methods 0.000 abstract 1
- 238000001514 detection method Methods 0.000 description 23
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
- 201000010099 disease Diseases 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 238000000034 method Methods 0.000 description 8
- 241000219061 Rheum Species 0.000 description 6
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 241000143476 Bidens Species 0.000 description 4
- 241000842328 Bidens bipinnata Species 0.000 description 4
- 244000025254 Cannabis sativa Species 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- 239000004382 Amylase Substances 0.000 description 3
- 102000013142 Amylases Human genes 0.000 description 3
- 108010065511 Amylases Proteins 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 235000019418 amylase Nutrition 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 210000000496 pancreas Anatomy 0.000 description 3
- 235000021395 porridge Nutrition 0.000 description 3
- 238000010926 purge Methods 0.000 description 3
- 230000000306 recurrent effect Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 206010059866 Drug resistance Diseases 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- 108010019160 Pancreatin Proteins 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 240000005498 Setaria italica Species 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- 108090000340 Transaminases Proteins 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- 229940055695 pancreatin Drugs 0.000 description 2
- 235000002252 panizo Nutrition 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 102000014898 transaminase activity proteins Human genes 0.000 description 2
- 230000010415 tropism Effects 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- 108010050201 2-hydroxybutyrate dehydrogenase Proteins 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 208000007743 Acute Abdomen Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 244000247747 Coptis groenlandica Species 0.000 description 1
- 235000002991 Coptis groenlandica Nutrition 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 241000522190 Desmodium Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 238000008789 Direct Bilirubin Methods 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 206010061217 Infestation Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 1
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 1
- 201000008197 Laryngitis Diseases 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 240000003433 Miscanthus floridulus Species 0.000 description 1
- 102000010909 Monoamine Oxidase Human genes 0.000 description 1
- 108010062431 Monoamine oxidase Proteins 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033654 Pancreatitis necrotising Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- -1 and the nature Substances 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 210000000078 claw Anatomy 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 235000005686 eating Nutrition 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- OYFJQPXVCSSHAI-QFPUQLAESA-N enalapril maleate Chemical compound OC(=O)\C=C/C(O)=O.C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(O)=O)CC1=CC=CC=C1 OYFJQPXVCSSHAI-QFPUQLAESA-N 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000004203 pancreatic function Effects 0.000 description 1
- 210000004923 pancreatic tissue Anatomy 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 206010034674 peritonitis Diseases 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 208000020029 respiratory tract infectious disease Diseases 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000009528 severe injury Effects 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Abstract
The invention relates to a traditional Chinese medicine composition for treating pancreatitis and application thereof, wherein the traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 10-20 g of bidens pilosa, 10-20 g of rheum officinale, 10-20 g of chinaberry fruit, 5-15 g of swertia mileensis and 3-8 g of liquorice. The traditional Chinese medicine composition disclosed by the invention is used for screening the optimal formula ratio according to the pathogenesis dialectical treatment of pancreatitis, the raw materials of the traditional Chinese medicine composition are common traditional Chinese medicines, the raw materials are cheap, the preparation is simple and convenient, no toxic or side effect exists, the treatment cost is low, the taking is convenient, the cure time is short, the safety and no wound can be realized, the pain of a patient can be relieved, other side effects caused by surgical treatment or chemical medicine taking can be effectively avoided, the economic burden of the family and the society of the patient can be relieved, and the traditional Chinese medicine composition has important application value and practical significance.
Description
Technical Field
The invention belongs to the technical field of traditional Chinese medicine preparations in the field of medicines, and particularly relates to a traditional Chinese medicine composition for treating pancreatitis and application thereof.
Background
Pancreatitis is a disease caused by the self-digestion of protease, is called abdominal pain and diarrhea in traditional Chinese medicine, is one of the common diseases of adults and can be divided into acute pancreatitis and chronic pancreatitis. Acute pancreatitis is a common disease in the digestive department, acute pancreatitis is an inflammatory reaction which causes pancreatin to be activated in pancreas to cause self digestion, edema, hemorrhage and even necrosis of pancreatic tissues, can be accompanied or not accompanied by other organ function changes, and is a common acute abdomen disease in a digestive system. The main symptoms of acute pancreatitis are abdominal pain, nausea, vomiting and fever, while hemorrhagic necrotizing pancreatitis can cause shock, high fever, jaundice, abdominal distension to enteroparalysis, peritoneal stimulation, subcutaneous blood stasis and the like. Clinically, the medicine is characterized by acute epigastric pain, nausea, vomiting, fever, pancreatin increase and the like. Chronic pancreatitis refers to recurrent or persistent inflammatory disease of pancreas, and pancreatic acinar tissue is gradually replaced by fibrous tissue, resulting in severe damage to pancreatic function and obvious disorder of food digestion. Patients often have recurrent epigastric pain, the severe pain is often accompanied by nausea and vomiting, and the epigastric part feels uncomfortable and uncomfortable after eating greasy food.
Along with the improvement of living standard and the change of eating habits, the incidence rate of the disease is increased. In the prior art, operations or chemical medicines are mostly adopted for treating pancreatitis, the operations cause great secondary damage to patients, general patients are not easy to accept, the chemical medicines are used for treating, symptoms can be relieved in a short time, but the traditional Chinese medicine cannot be fundamentally adjusted, can treat symptoms and root causes, has great adverse reactions, and seriously affects the life quality of people. Moreover, if the medicine is taken for a long time, the medicine resistance of pathogenic bacteria can be generated, the damage to the liver and the kidney can be caused, if the medicine is taken, the treatment cost is high, at least about 10 ten thousand are needed, the economic burden is heavy for many families, and the high medical expense can not be born by many families. In recent years, traditional Chinese medicine has a great progress in the aspect of treating pancreatitis, the traditional Chinese medicine treatment starts from pathogenesis, adopts an integral treatment method, reasonably selects the prescription for medication, and performs medical treatment according to syndrome differentiation, so that the effects of relieving pain and improving the internal and external secretion function of pancreas are achieved, and the effects of treating both principal and secondary aspect of disease are achieved.
Miao medicine has been long-running, and developed to date, Miao medicine has a history of three to four thousand years. The medicine of the Miao nationality is often connected with words such as mystery and miracle, forms a system by oneself, especially is famous for the therapy of treating internal diseases by external therapy, and becomes a wonderful flower of national medicine. The Miao nationality also has the theory of thousand years Miao medicine and ten thousand years Miao medicine. Miao medicine is an important component of traditional medicine in China, and Miao nationality has the saying of thousand years Miao medicine and ten thousand years Miao medicine. The inventor of the invention is used as a Guizhou Miao medicine for years, in order to effectively treat more patients and reduce the economic burden of families, the invention develops a traditional Chinese medicine composition which has the advantages of simple composition, scientific and reasonable proportion, low treatment cost, safety, effectiveness and no toxic or side effect, has good treatment effect on pancreatitis, can improve the curative effect, shorten the course of disease, and prevent the patients from suffering from operation pain or drug resistance caused by long-term taking of chemical drugs, thereby reducing the economic burden of the patients and the society, and has important application value and practical significance.
Disclosure of Invention
The invention aims to solve the technical problems of high treatment cost and easy recurrence in the prior art, and provides a traditional Chinese medicine composition with simple formula and low treatment cost.
In order to solve the technical problems, the technical scheme adopted by the invention is as follows: a traditional Chinese medicine composition for treating pancreatitis comprises the following raw materials: 10-20 g of bidens pilosa, 10-20 g of rheum officinale, 10-20 g of chinaberry fruit, 5-15 g of swertia mileensis and 3-8 g of liquorice.
Further, the traditional Chinese medicine composition for treating pancreatitis provided by the invention comprises the following raw materials: 13-16 g of bidens pilosa, 13-16 g of rheum officinale, 13-16 g of chinaberry fruit, 8-12 g of swertia mileensis and 4-6 g of liquorice.
Further, as a preferred technical scheme, the traditional Chinese medicine composition for treating pancreatitis is characterized by comprising the following raw materials: 15g of bidens pilosa, 15g of rheum officinale, 15g of chinaberry fruit, 9g of swertia mileensis and 5g of liquorice.
Further, the traditional Chinese medicine composition for treating pancreatitis is an oral liquid decoction.
Furthermore, the invention also discloses application of the traditional Chinese medicine composition in a medicine for treating pancreatitis, wherein the traditional Chinese medicine composition is prepared into decoction and is applied to the medicine for treating acute pancreatitis or chronic pancreatitis.
The traditional Chinese medicine composition is used for treating acute pancreatitis or chronic pancreatitis, and the dosage of the traditional Chinese medicine composition is as follows: the raw materials are taken according to the raw material ratio, water is added for decocting to obtain decoction, the decoction is taken orally, 1 dose is taken every day, 1 dose can be taken for 3-4 times, at least 4-5 hours are required to be separated after each time of taking, 150-200 ml of decoction is taken every time, the decoction needs to be decocted to be taken orally before each time of taking, the water adding amount is 3-5 times of the total weight of the traditional Chinese medicine composition during first decocting, after the decoction is boiled by big fire, the decoction is decocted by small fire, and the decoction is poured out and is taken orally directly after cooling; during the second decoction, the water adding amount is 2-4 times of the total weight of the traditional Chinese medicine composition, and the decoction method is the same as that of the first decoction; the water adding amount is gradually reduced in the third or fourth decoction, and the decoction method is the same as that of the first decoction.
The raw materials adopted by the invention are Bidens bipinnata, namely Bidens bipinnata, Bidens shrimp, crab claw grass, Bidens furcifera, viscid grass, desmodium and bean dreg grass, wherein the Bidens bipinnata is an annual herbaceous plant, has upright stem, 30-100 cm high, blunt quadrangular shape, no hair or soft hair with extremely sparse upper part, and the diameter of the base part can reach 6 mm. Bidens pilosa is a folk common herbal medicine, has the effects of clearing away heat and toxic materials, dissipating blood stasis, promoting blood circulation and reducing swelling, and is used for treating appendicitis, nephritis, cholecystitis, enteritis, bacillary dysentery, acute icteric hepatitis, peritonitis, gastroenteritis, rheumatic arthralgia, malaria, upper respiratory infection, tonsillitis, laryngitis and amenorrhea, and is externally used for treating diseases such as sore and furuncle, scald, venomous snake bite, traumatic injury, swelling and pain, skin infection, infantile convulsion, malnutrition and the like.
Rhubarb is a common Chinese patent medicine, and the nature, flavor and channel tropism are as follows: cold in nature and bitter in taste. It enters spleen meridian, stomach meridian, large intestine meridian, liver meridian and pericardium meridian. The efficacy and the effect are as follows: has effects in purging heat, relieving constipation, cooling blood, removing toxic materials, removing blood stasis, dredging channels, clearing away heat, and eliminating dampness.
The fruit of Melia azedarach is the fruit of Melia azedarach, and the nature and taste are as follows: bitter and cold. The main effects are as follows: soothing liver, moving qi, alleviating pain, expelling parasites. Can be used for treating distending pain of chest, hypochondrium and abdomen, hernia pain, and abdominal pain due to parasitic infestation.
The swertia mileensis is also called swertia mileensis, four-yellow grass, water coptis and splanchna flower, is a common Chinese herbal medicine in folk, and has the efficacies of clearing heat, removing dampness, purging fire and detoxifying.
The liquorice is a common bulk medicinal material and is a medicinal and edible variety, and the nature and taste are as follows: sweet and neutral. Meridian tropism: enter spleen, stomach and lung meridians. The functional indications are as follows: for internal organs with pathogenic cold and heat, strengthen tendons and bones, strengthen muscles, remove toxicity, lighten body and prolong life after long-term use; unprocessed with the action of purging fire-heat, cooked with the action of dispelling exterior cold, relieving sore throat, removing pathogenic heat, relieving healthy qi, nourishing yin and blood, tonifying spleen and stomach, moistening lung. Licorice root also has the effect of harmonizing the properties of the drugs.
Compared with the prior art, the traditional Chinese medicine composition for treating pancreatitis and the application thereof have the beneficial effects that: the optimal formula proportion is screened according to the pathogenesis syndrome differentiation and treatment of pancreatitis, the raw materials of the traditional Chinese medicine are common traditional Chinese medicines, the raw materials are low in price and low in cost, and have no toxic or side effect, the traditional Chinese medicine is used for treating patients suffering from pancreatitis, not only can be suitable for chronic pancreatitis, but also has a very good effect on patients suffering from acute pancreatitis, the cure rate reaches 99%, and the curative effect is obvious. After the traditional Chinese medicine composition is taken, the effect can be achieved in one day, porridge and drinking water can be taken in the afternoon by taking the traditional Chinese medicine composition twice in the morning and at noon, and the patient can be cured after the traditional Chinese medicine composition is continuously taken for 3-4 days. When the traditional Chinese medicine is used for treatment in a hospital, water drinking is not allowed generally in the treatment process, and the traditional Chinese medicine is used for treatment in a long-term medicine taking mode, so that the cost is very high, the drug resistance can be generated for patients, and meanwhile psychological shadow can be generated.
Therefore, compared with the existing treatment scheme, the traditional Chinese medicine composition for treating patients with pancreatitis has the advantages of low treatment cost, convenience in taking, short cure time, safety and no wound, can relieve pain of the patients, can effectively avoid other side effects caused by surgical treatment or chemical medicine taking, can also relieve the economic burden of families and society of the patients, and has important application value and practical significance.
Detailed Description
In order to more fully explain the practice of the invention, the invention is further described with reference to the following specific examples. The examples are given solely for the purpose of illustration and are not intended to limit the scope of the invention.
Example 1:
a traditional Chinese medicine composition for treating pancreatitis comprises the following raw materials in parts by weight: 10 g of spanishneedles herb, 10 g of rhubarb, 10 g of chinaberry fruit, 5g of swertia mileensis and 3 g of liquorice. The Chinese medicinal composition is prepared into decoction and is used for treating patients suffering from acute pancreatitis or chronic pancreatitis.
The usage and dosage are as follows: the raw materials are taken according to the raw material ratio, water is added for decocting to obtain decoction, the decoction is taken orally, 1 dose is taken every day, 1 dose can be taken for 3-4 times, at least 4-5 hours are required to be separated after each time of taking, 150-200 ml of decoction is taken every time, the decoction needs to be decocted to be taken orally before each time of taking, the water adding amount is 3-5 times of the total weight of the traditional Chinese medicine composition during first decocting, after the decoction is boiled by big fire, the decoction is decocted by small fire, and the decoction is poured out and is taken orally directly after cooling; during the second decoction, the water adding amount is 2-4 times of the total weight of the traditional Chinese medicine composition, and the decoction method is the same as that of the first decoction; the water adding amount is gradually reduced in the third or fourth decoction, and the decoction method is the same as that of the first decoction.
Example 2:
a traditional Chinese medicine composition for treating pancreatitis comprises the following raw materials in parts by weight: 13 g of spanishneedles herb, 13 g of rhubarb, 13 g of chinaberry fruit, 8g of swertia mileensis and 4 g of liquorice. The Chinese medicinal composition is prepared into decoction and is used for treating patients suffering from acute pancreatitis or chronic pancreatitis.
The amount used was the same as in example 1.
Example 3:
a traditional Chinese medicine composition for treating pancreatitis comprises the following raw materials in parts by weight: 15g of bidens bipinnata, 15g of rhubarb, 15g of chinaberry fruit, 9g of swertia mileensis and 5g of liquorice. The Chinese medicinal composition is prepared into decoction and is used for treating patients suffering from acute pancreatitis or chronic pancreatitis.
The amount used was the same as in example 1.
Example 4:
a traditional Chinese medicine composition for treating pancreatitis comprises the following raw materials in parts by weight: 16g of bidens pilosa, 16g of rhubarb, 16g of chinaberry fruit, 12g of swertia mileensis and 6g of liquorice. The Chinese medicinal composition is prepared into decoction and is used for treating patients suffering from acute pancreatitis or chronic pancreatitis.
The amount used was the same as in example 1.
Example 5:
a traditional Chinese medicine composition for treating pancreatitis comprises the following raw materials in parts by weight: 20g of bidens pilosa, 20g of rhubarb, 20g of chinaberry fruit, 15g of swertia mileensis and 8g of liquorice. The Chinese medicinal composition is prepared into decoction and is used for treating patients suffering from acute pancreatitis or chronic pancreatitis.
The amount used was the same as in example 1.
In order to illustrate the treatment effect of the traditional Chinese medicine composition, the cure rate reaches 99% through years of practice, and the curative effect is very obvious. After the traditional Chinese medicine composition is taken, the effect can be achieved in one day, porridge and drinking water can be taken in the afternoon by taking the traditional Chinese medicine composition twice in the morning and at noon, and the patient can be cured after the traditional Chinese medicine composition is continuously taken for 3-4 days. The experimental effect can be illustrated from the following typical cases:
case 1:
zhao, woman, 65 years old, green man, hospitalization number: 2019007057, the patient complaints that continuous epigastric pain is already 8 hours, and the biochemical detection is carried out in the national hospital of Buyi family of Miao nationality, Guanling, 4 and 5 days in 2019, wherein the detection result of glutamic-pyruvic transaminase is 285, and the reference range is 0-40; 872 is the detection result of glutamic-oxalacetic transaminase, and 0-40 is the reference range; the detection result of the foxtail millet/the foxtail millet is 3.1, and the reference range is 0.8-1.5; the detection result of the alkaline phosphatase is 174, and the reference range is 35-152; the detection result of the glutamic-oxalacetic transaminase is 499, and the reference range is 4-52; the detection result of the monoamine oxidase is 22.7, and the reference range is 0-17.0; the detection result of the total bile acid is 48.3, and the reference range is 0-10.0; the detection result of the direct bilirubin is 10.8, and the reference range is 0-7; the detection result of the 5-nucleotidase is 38.0, and the reference range is 0-10; the detection result of the urea is 8.0, and the reference range is 2.7-7.7; the detection result of the total cholesterol is 5.9, and the reference range is 0.4-5.4; the detection result of the high-density lipoprotein cholesterol is 2.02, and the reference range is 1.28-1.72; the detection result of the lipoprotein is 335.6, and the reference range is 0-300.0; the detection result of the lactate dehydrogenase is 890, and the reference range is 104-248; the detection result of the alpha-hydroxybutyrate dehydrogenase is 407, and the reference range is 59-128; the detection result of the amylase is 3195, and the reference range is 15-150; according to the detection data, the detection indexes of the pancreatitis detection data exceed the reference range, and the indexes of the amylase are an important index for judging the pancreatitis, particularly, the detection result of the amylase is 3195, and the reference range is 15-150, so that the detection indexes greatly exceed the reference range. And the acute pancreatitis is clinically diagnosed by color Doppler ultrasound examination. The treatment in the hospital for 2 days is not good; after discharge from hospital, the Chinese medicinal composition is orally taken for 1 day, the decoction is taken for 3 times, so that the disease is improved, the symptoms basically disappear, and the patient is cured after continuously taking the Chinese medicinal composition for 3 days. Finally, the physical indexes of the patient body are recovered to be normal through hospital detection, and the family members of the patient are satisfied.
Case 2:
wu, women, 45 years old, Guanling Hua Jiangwavazhai, through patient complaints, has been hospitalized in a certain hospital in Guiyang City of Guizhou province for about 2 months, during the treatment period of the hospital, the disease condition is not good, and the occurrence of recurrent attacks occurs; after discharge from hospital, the Chinese medicinal composition is orally taken for 1 day, the decoction is taken for 4 times, so that the effect is improved, porridge can be taken in the afternoon, symptoms basically disappear, and the patient can be cured after continuously taking the Chinese medicinal composition for 4 days.
Case 3:
liu Yi, women, 43 years old, Guanling pril countryside, through patient complaints, has already been treated in a certain hospital in Anshun city of Guizhou province for 1 week, during the hospital treatment period, the state of an illness is not good, after leaving the hospital, through the introduction of people, adopt the Chinese medicinal composition of the invention, orally take 1 day decoction, divide into 3 times and take medicine, just good, after continuing taking medicine for 4 days, the patient's state of an illness is fully recovered.
Case 4:
according to patient complaints, the traditional Chinese medicine composition belongs to acute pancreatitis, is hospitalized for 1 night in a certain hospital in Huajiang town, is treated by a hanging drop infusion mode, is required to enter a critical care unit for treatment in the next day, or is transferred to a municipal hospital with good treatment conditions or a provincial hospital for treatment, and is introduced by acquaintances after discharge due to family economic reasons.
Case 5:
after the patient mainly complains that the Zhao, a woman is 48 years old and the Guanling Huajiang village group has suffered from the disease for four times, the chronic pancreatitis belongs to the chronic pancreatitis, the traditional Chinese medicine composition is orally taken for 1 day, the decoction is divided into 3 times of oral administration, so that the disease is improved, and the patient is cured after continuously taking the medicine for 4 days.
Case 6:
the patients in 62 years old and women in Guanling Huajiang town have been treated by oral complaints of children and the mothers have pancreatitis, and the patients are not cured by multi-party treatment, and the families have prepared the aftermath of the old, and the later mature people introduce the medicine.
Case 7:
the patient mainly complains about Miscanthus village in Ninghuajiangzhengzhengqianjiang county, has suffered from the disease for three times once, and belongs to the chronic pancreatitis.
The above description is only an example of the present invention, and is not intended to limit the scope of the present invention, and all the insubstantial modifications made by the method, or the technical solutions of the present invention, or the direct application of the method, the technical solutions of the present invention to other fields without any modifications, are within the scope of the present invention.
Claims (5)
1. A traditional Chinese medicine composition for treating pancreatitis is characterized by comprising the following raw materials: 10-20 g of bidens pilosa, 10-20 g of rheum officinale, 10-20 g of chinaberry fruit, 5-15 g of swertia mileensis and 3-8 g of liquorice.
2. The traditional Chinese medicine composition for treating pancreatitis according to claim 1, wherein the traditional Chinese medicine composition is prepared from the following raw materials: 13-16 g of bidens pilosa, 13-16 g of rheum officinale, 13-16 g of chinaberry fruit, 8-12 g of swertia mileensis and 4-6 g of liquorice.
3. The traditional Chinese medicine composition for treating pancreatitis according to claim 2, wherein the traditional Chinese medicine composition is prepared from the following raw materials: 15g of bidens pilosa, 15g of rheum officinale, 15g of chinaberry fruit, 9g of swertia mileensis and 5g of liquorice.
4. The traditional Chinese medicine composition for treating pancreatitis according to any one of claims 1 to 3, wherein: the traditional Chinese medicine composition is an oral liquid decoction.
5. The use of the Chinese medicinal composition according to claim 4 in a medicament for treating pancreatitis, which is characterized in that: the traditional Chinese medicine composition is applied to medicines for treating acute pancreatitis or chronic pancreatitis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911098853.2A CN110613754A (en) | 2019-11-12 | 2019-11-12 | Traditional Chinese medicine composition for treating pancreatitis and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911098853.2A CN110613754A (en) | 2019-11-12 | 2019-11-12 | Traditional Chinese medicine composition for treating pancreatitis and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110613754A true CN110613754A (en) | 2019-12-27 |
Family
ID=68927562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201911098853.2A Pending CN110613754A (en) | 2019-11-12 | 2019-11-12 | Traditional Chinese medicine composition for treating pancreatitis and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110613754A (en) |
-
2019
- 2019-11-12 CN CN201911098853.2A patent/CN110613754A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101036732B (en) | Chinese medicine preparation for esophagus cancer and its compounding process | |
| CN102872362B (en) | Traditional Chinese medicine for treating chronic cholecystitis | |
| CN104069441A (en) | Traditional Chinese medicine composition for treating urinary organs calculus | |
| CN110613754A (en) | Traditional Chinese medicine composition for treating pancreatitis and application thereof | |
| CN103735630B (en) | A kind of Chinese medicine for the treatment of gout | |
| CN100333779C (en) | Chinese medicine prepn for treating vaginitis and cervicitis | |
| CN103520492B (en) | A kind of liniment of prevention and therapy gout and preparation method | |
| CN102274428B (en) | Pharmaceutical composition with effect on treating irritable bowel syndrome and preparation method and application thereof | |
| CN1970009B (en) | Chinese medicinal suppository for treating piles quickly | |
| CN103893488A (en) | Chinese medicine preparation for treating migraine and preparation method thereof | |
| CN109394885A (en) | A kind of Chinese materia medica preparation of anti-nonalcoholic fatty liver | |
| CN103520638B (en) | A kind of Traditional Chinese medicine compound composition for the treatment of prostate hyperplasia and preparation method thereof and application thereof | |
| CN107998230A (en) | A kind of Chinese medicine for treating swelling and aching of gum and preparation method thereof | |
| CN108030835A (en) | A kind of Chinese medicine of quick treatment swelling and aching of gum and preparation method thereof | |
| CN108743850A (en) | A kind of Chinese medicine preparation for nursing period acute mastitis | |
| CN113633748B (en) | Medicine for treating spontaneous bacterial peritonitis damp-heat stasis syndrome of liver cirrhosis and preparation method thereof | |
| CN101912463B (en) | Medicament for treating infantile rectocele and preparation method thereof | |
| CN106389634A (en) | Traditional Chinese medicine composition for treating hemorrhoids | |
| CN105521435A (en) | Sterilization and disinfection liquid for promoting wound healing, and preparation method thereof | |
| CN106728835A (en) | A kind of Chinese medicine for treating diabetes | |
| CN104524349A (en) | Health-care tea used for constipation | |
| CN105079487A (en) | Traditional Chinese medicine composition for treating heat stranguria | |
| CN106551979A (en) | A kind of film for treating oral ulcer and preparation method thereof | |
| CN115120647A (en) | Anti-gout pharmaceutical composition and application thereof | |
| CN110090241A (en) | A kind of traditional Chinese medicine for external application and its preparation method and application for treating vasculitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191227 |
|
| RJ01 | Rejection of invention patent application after publication |